10-year trend in quantity and quality of pediatric randomized controlled trials published in mainland China: 2002–2011

BMC Pediatrics

Yun-Zhu Lin¹  Lu Han¹  Yi Liang¹  Li-Nan Zeng¹  Ling-Li Zhang¹  Chun-Song Yang¹ 

[1] Pharmacy Department, West China Second Hospital, Sichuan University, No. 20, Section 3, Renmin South Road, Cheng du 610041, Sichuan Province, China

关键词: Quality assessment;    Randomized controlled trials;    Drugs;    Children;   

Others  :  1144676
DOI  :  10.1186/1471-2431-13-113

 received in 2012-10-15, accepted in 2013-07-16,  发布年份 2013

【 摘 要 】

Background

Quality assessment of pediatric randomized controlled trials (RCTs) in China is limited. The aim of this study was to evaluate the quantitative trends and quality indicators of RCTs published in mainland China over a recent 10-year period.

Methods

We individually searched all 17 available pediatric journals published in China from January 1, 2002 to December 30, 2011 to identify RCTs of drug treatment in participants under the age of 18 years. The quality was evaluated according to the Cochrane quality assessment protocol.

Results

Of 1287 journal issues containing 44398 articles, a total of 2.4% (1077/44398) articles were included in the analysis. The proportion of RCTs increased from 0.28% in 2002 to 0.32% in 2011. Individual sample sizes ranged from 10 to 905 participants (median 81 participants); 2.3% of the RCTs were multiple center trials; 63.9% evaluated Western medicine, 32.5% evaluated traditional Chinese medicine; 15% used an adequate method of random sequence generation; and 10.4% used a quasi-random method for randomization. Only 1% of the RCTs reported adequate allocation concealment and 0.6% reported the method of blinding. The follow-up period was from 7 days to 96 months, with a median of 7.5 months. There was incomplete outcome data reported in 8.3%, of which 4.5% (4/89) used intention-to-treat analysis. Only 0.4% of the included trials used adequate random sequence allocation, concealment and blinding. The articles published from 2007 to 2011 revealed an improvement in the randomization method compared with articles published from 2002 to 2006 (from 2.7% to 23.6%, p = 0.000).

Conclusions

In mainland China, the quantity of RCTs did not increase in the pediatric population, and the general quality was relatively poor. Quality improvements were suboptimal in the later 5 years.

【 授权许可】

   
2013 Yang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 1.

Figure 3.

【 参考文献 】

• [1]Budetti PP: Ensuring safe and effective medications for children. JAMA 2003, 290:950-951.
• [2]Morales-Olivas FJ, Morales-Carpi C: Clinical trials in children. Rev Recent Clin Trials 2006, 1:251-258.
• [3]Caldwell PH, Butow PN, Craig JC: Parents’ attitudes to children's participation in randomized controlled trials. J Pediatr 2003, 142:554-559.
• [4]Al-Namankany AA, Ashley P, Moles DR, Parekh S: Assessment of the quality of reporting of randomized clinical trials in paediatric dentistry journals. Int J Paediatr Dent 2009, 19:318-324.
• [5]Crocetti MT, Amin DD, Scherer R: Assessment of risk of bias among pediatric randomized controlled trials. Pediatrics 2010, 126:298-305.
• [6]Hamm MP, Hartling L, Milne A, Tjosvold L, Vandermeer B, Thomson D, Curtis S, Klassen TP: A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr 2010, 22:96.
• [7]Wu T, Li Y, Bian Z, Liu G, Moher D: Randomized trials published in some Chinese journals: how many are randomized? Trials 2009, 10:46. BioMed Central Full Text
• [8]Higgins J, Green S (Eds): In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. 2011. The Cochrane Collaboration, Available from http://www.cochrane-handbook.org webcite
• [9]Martinez-Castaldi C, Silverstein M, Bauchner H: Child versus adult research: the gap in high-quality study design. Pediatrics 2008, 122:52-57.
• [10]Campbell H, Surry SA, Royle EM: A review of randomised controlled trials published in Archives of Disease in Childhood from 1982–96. Arch Dis Child 1998, 79:192-197.
• [11]Cohen E, Uleryk E, Jasuja M, Parkin PC: An absence of pediatric randomized controlled trials in general medical journals, 1985–2004. J Clin Epidemiol 2007, 60:118-123.
• [12]Cohen E, Goldman RD, Ragone A, Uleryk E, Atenafu EG, Siddiqui U, Mahmoud N, Parkin PC: Child vs adult randomized controlled trials in specialist journals: a citation analysis of trends, 1985–2005. Arch Pediatr Adolesc Med 2010, 164:283-288.
• [13]Wang G, Mao B, Xiong ZY, Fan T, Chen XD, Wang L, Liu GJ, Liu J, Guo J, Chang J, Wu TX, Li TQ: The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clin Ther 2007, 29:1456-1467.
• [14]Menson EN, Walker AS, Gibb DM: Clinical trials in children. Lancet 2004, 364:2176-2177.
• [15]Roberts R, Rodriguez W, Murphy D, Crescenzi T: Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 2003, 290:905-911.
• [16]Santos DB, Clavenna A, Bonati M, Coelho HL: Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol 2008, 64:1111-1118.
• [17]McIntyre J, Conroy S, Avery A, Corns H, Choonara I: Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000, 83:498-501.
• [18]Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van den Anker J: Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000, 320:79-82.
• [19]t Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN: Unapproved and off-label use of drugs in a children's hospital. N Engl J Med 2000, 343:1125.
• [20]Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS: Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007, 29:361-367.
• [21]Palcevski G, Skocibusic N, Vlahovic-Palcevski V: Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey. Eur J Clin Pharmacol 2012, 68:1073-1077.
• [22]Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H: Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009, 34:277-287.
• [23]Gavrilov V, Lifshitz M, Levy J, Gorodischer R: Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2000, 2:595-597.
• [24]Zhang LL, Li YP, Hu D, Zeng LN, Huang L, Chen M, Yang CS: Off-label Drug Use in Pediatric Wards of West China Second University Hospital in 2010: A Cross Sectional Study. Chin J Evid-Based Med 2012, 2:161-167.
• [25]Crowley E, Williams R, Cousins D, Williams DC: Medication errors in children: a descriptive summary of medication error reports submitted to the United States Pharmacopeia. Curr Ther Res 2001, 62:627-640.
• [26]Smyth RL, Weindling AM, Weindling , 2: Research in children: ethical and scientific aspects. Lancet 1999, 354:SII21-SII24.
• [27]Federman DD, Hanna KE, Rodriguez LL: Responsible Research: A Systems Approach to Protecting Research Participants. Washington, DC: National Academies Press; 2002.
• [28]Hopewell S, Dutton S, Yu LM: The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010, 340:c723.
• [29]Sinha S, Ashby E, Jayaram R, Grocott MP: Quality of reporting in randomized trials published in high-quality surgical journals. J Am Coll Surg 2009, 209:565-571. e1
• [30]Uetani K, Nakayama T, Ikai H, Yonemoto N, Moher D: Quality of reports on randomized controlled trials conducted in Japan: evaluation of adherence to the CONSORT statement. Intern Med 2009, 48:307-313.
• [31]Juni P, Altman DG, Egger M: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
• [32]Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
• [33]Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336:601-605.
• [34]Kober T, Trelle S, Engert A: Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer Inst 2006, 98:620-625.
• [35]Bafeta A, Dechartres A, Trinquart L, Yavchitz A, Boutron I, Ravaud P: Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ 2012, 344:e813.